RE-EVALUATION

作品数：65被引量：152H指数：6
导出分析报告
相关领域：医药卫生更多>>
相关作者：夏祖贵沈韬更多>>
相关机构：苏州大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家社会科学基金The Royal Society更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Chinese Journal of Integrative Medicinex
共 条 记 录，以下是1-2
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Post-marketing Re-evaluation of Tongxiening Granules (痛泻宁颗粒) in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome:A Multi-center,Randomized,Double-Blind,Double-Dummy and Positive Control Trial被引量：15
《Chinese Journal of Integrative Medicine》2019年第12期887-894,共8页TANG Xu-dong ZHANG Sheng-sheng HOU Xiao-hua LI Zhen-hua CHEN Su-ning FENG Pei-min YANG Xiao-nan LI Hui-zhen WU Jie-qiong XIA Pei-jun YANG Xiao-jun ZHOU Heng-jun WANG Hai-yan AI Yao-wei LI Kang 
Objective: To evaluate the efficacy and safety of Tongxiening Granules(痛泻宁颗粒, TXNG) in the treatment of irritable bowel syndrome with predominant diarrhea(IBS-D). Methods: A randomized, double-blind, double-dummy...
关键词：Tongxiening GRANULES IRRITABLE bowel syndrome with predominant diarrhea POST-MARKETING evaluation RANDOMIZED controlled TRIAL 
Regulations and Guidelines Should Be Strengthened Urgently for Re-evaluation on Post-marketing Medicines in China被引量：48
《Chinese Journal of Integrative Medicine》2013年第7期483-487,共5页谢雁鸣 田峰 
Supported by the Research on Key Techniques of Reevaluation of Post-marketing Chinese Medicines,the Ministry of Science and Technology(No.2009ZX09502-030);the Sixth-Science Foundation of Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences(No. Z0215)
This paper reviewed the situation of regulations and guidelines on post-marketing medicines in the developed countries and in China. The developed countries have accumulated a lot of empirical principles and technique...
关键词：post-marketing medicines RE-EVALUATION regulations and guidelines PHARMACOVIGILANCE 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部